TestAVec Researchers Uncover Possible Reasons For Side Effects of HIV-1 Lentiviral Vectors
TestAVec CSO, Professor Michael Themis, also Head of the Gene Therapy research group at Brunel University London, and his team have...
News
Search
- Dec 24, 2021
Merry Christmas from TestAVec
From all of us at TestAVec, we wish you a wonderful Christmas and new year. We look forward to working with you in 2022.
- Dec 9, 2021
The real patient benefit of gene therapy highlighted by skin transplant
In 2015, a 7 year old patient was presented at a hospital in Germany with severe burns. The patient had suffered debilitating blisters...
- Nov 23, 2021
Promising gene therapy trial for haemophillia
A Phase 1/2 gene therapy trial conducted at the Children's hospital of Philadelphia have shown promising results in the treatment of...
- Oct 15, 2021
Positive news for DMD gene therapy
Recent clinical trial results for SRP-9001 show high levels of sustained improvements in patients suffering from Duchene muscular...